The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,700.00
Ask: 1,810.00
Change: 0.00 (0.00%)
Spread: 110.00 (6.471%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 11th Mar 2013 07:23

Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling.Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral.Anite Group: Invetsec downgrades from buy to hold with a target price of 157p.Aviva: Citigroup reduces target price from 479p to 432p reiterating its buy recommendation. Bank of America shifts target price from 330p to 350p, while its neutral rating is maintained.Avocet Mining: Investec cuts target price from 28.60p to 24p and keeps a hold recommendation.Babcock: JP Morgan ups target price from 1120p to 1230p, while maintaining an overweight rating.Bovis Homes: UBS increases target price from 560p to 700p retaining a neutral rating.BP: Deutsche Bank moves target price from 500p to 520p, while leaving its buy recommendation unaltered.British American Tabacco: Investec raises target price from 3350p to 3800p reiterating a buy recommendation.Capita: Westhouse Securities takes target price from 661p to 755p, while maintaining a sell recommendation.CAP-XX: Having had both its target price and recommendation under review, Cantor Fitzgerald rates a target price of 13p and a buy recommendation.Carillion: UBS lowers target price from 240p to 230p and reiterates a sell recommendation.Chime Communications: Investec ups target price from 265p to 300p and keeps a buy recommendation.Clinigen Group: Numis revises target price from 265p to 310p and stays with its buy recommendation.Cobham: Morgan Stanley ups target price from 175p to 195p and maintains an underweight rating. Exane BNP moves target price from 205p to 230p, while staying with its neutral rating.Daily Internet: Merchant Securities initiates with a target price of 8p and a buy recommendation.Dixons Retail: Deutsche Bank shifts target price from 31p to 36p keeping a buy recommendation.Escher Group: Panmure Gordon increases target price from 384p to 410p, while maintaining a buy recommendation.GlaxoSmithKline: Deutsche Bank increases target price from 1440p to 1530p and retains a hold recommendation. Espirito Santo shifts target price from 525p to 533p, while keeping a neutral rating.Hammerson: UBS moves target price from 525p to 560p, while leaving its buy recommendation unchanged.Herencia Resources: WH Ireland downgrades from buy to a speculative buy.HG Capital Trust: Oriel Securities revises target price from 1065p to 1130p and stays with its hold recommendation.Hiscox: Westhouse Securities ups target price from 525p to 533p reiterating a neutral rating.Howden Joinery: Numis raises target price from 245p to 260p keeping an add rating.HSBC Holdings: Exane BNP cuts target price from 850p to 825p and stays with its outperform rating.Hunting: Liberum Capital raises target price from 770p to 826p, while its hold recommendation is kept.ICAP: UBS reduces target price from 330p to 305p and downgrades from neutral to sell.IMI: UBS revises target price from 1000p to 1100p, but still recommends selling.Intu Properties: Espirito Santo reduces target price from 320p to 295p keeping a sell recommendation.Ladbrokers: Panmure Gordon raises target price from 195p to 219p, while maintaining a hold recommendation. Bank of America moves target price from 235p to 260p and retains its buy recommendation.Lloyds Banking Group: Bank of America shifts target price from 65p to 70p and retains its buy recommendation.Marshalls: Citigroup moves target price from 96p to 110p staying with its neutral rating.Perform: JP Morgan raises target price from 416p to 451p and keeps its neutral rating.Petro Matad: Westhouse Securities upgrades from add to buy with a target price of 15p.Playtech: Deutsche Bank takes target price from 550p to 650p and stays with its buy recommendation.Pure Water: WH Ireland shifts target price from 8.25p to 9.75p and maintains a buy recommendation.Reckitt Benckiser: Bank of America raises target price from 5000p to 5250p and reiterates its buy recommendation.Sage: Analysts at Bank of America-Merrill Lynch have downgraded their view to underperform. Bank of America shifts target price from 320p to 330p, while downgrading to underperform.Schroders: Credit Suisse ups target price from 1800p to 2150p keeping a neutral rating.Standard Chartered: Exane BNP revises target price from 1700p to 1750op leaving its neutral rating unchanged.Standard Life: Bank of America increases target price from 340p to 375p keeping an underperform rating.SThree: Numis downgrades to hold with a target price of 350p.St Ives: Numis moves target price from 132p to 150p reiterating its buy recommendation.St Modwen Properties: Numis revises target price from 259p to 280p and downgrades to add.Tullet Prebon: UBS shifts target price from 244p to 250p, while downgrading from neutral to sell.UBM: UBS ups target price from 700p to 740p and reiterates a neutral rating. Citigroup moves target price from 734p to 749p, while its neutral rating is kept.William Hill: Bank of America takes target price from 315p to 420p and leaves its underperform rating unaltered.Wolseley: UBS raises target price from 2800p to 3375p and keeps a neutral rating.
More News
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.